Integrated Industrial, Logistics & Green Energy
ILG-1100 (BioFab) Industrial & Consumer Biotechnology Facility (Synthetic Biology)
Engineering life for a better tomorrow.
Vision and Identity
BioFab envisions a future engineered by biology. Through synthetic innovations, it creates sustainable materials and industrial enzymes that replace fossil-based products. BioFab pioneers a bioeconomy that blends science, sustainability, and human progress.
Architecture and Features
BioFabs architecture follows clean-lab and GMP standards, housing fermentation reactors and modular bioprocess suites. Transparent corridors showcase research activity while maintaining biosafety zoning. Climate and humidity controls ensure process integrity. Green walls and daylight tubes humanize the otherwise high-tech biotech facility.
Lifestyle and Experience
Within its white halls, scientists weave life from natures code. Enzymes bubble, bioplastics form, and the air hums with creation, not pollution. Every breakthrough feels like a heartbeat toward a better world. Its where science grows greener every day.
Sustainability and Innovation
BioFab replaces petrochemicals with biology, producing materials from renewable carbon sources. Synthetic biology and fermentation technologies lower environmental impact while enabling scalable innovation. Every product strengthens the circular bioeconomy and the path to a fossil-free industry.
Investment and Value
Synthetic biology manufacturing unlocks high-margin biotech exports for pharma, food, and materials. R&D-driven ecosystem attracts global joint ventures and grants. As the regions first bio-industrial hub, it positions BayaniCity in the forefront of the green biotech revolution.
A biotech hub producing bio-based materials, industrial enzymes, and eco-friendly consumer products. Using synthetic biology, it drives innovation in medicine, agriculture, and manufacturing. The facility reduces dependence on fossil-based inputs, strengthens bio-economy industries, and promotes sustainable growth while fostering collaboration between researchers, startups, and global biotech leaders.
State-of-the-art lab producing synthetic biology innovations for industry, medicine, and consumer goods, with advanced fermentation and gene-editing tools.
Key Features:
| Investment Highlights: | Synthetic biology facility serving materials and enzyme markets. |
| Value Proposition: | The Provinces First Synthetic Biology Facility |
| Benefits: | Global biotech market entry |
| Why it Matters: | Builds bioeconomy industries for global competitiveness |
| Role: | Builds bio-based industries |
| Core Objectives: | Innovation, sustainability, inclusivity |
| Mission Statement: | Bio-innovation for a cleaner world. |
| Key Features: | Bio-based materials, industrial enzymes |
| Land Area: | 35,200 sqm |
| Projected Gross Income per Year: | PHP 887,040,000.00 |
| Valuation: | PHP 89,812,800,000.00 |
| Initial Business Model: | Unit Lease |
| Main Business Model: | Biotech Production |
| 2nd Business Model: | Bio-Product Licensing |
| Other Income Streams: | Patents, R&D Grants |
| Estimated ROI Timeline: | 9 years |
Specifications:
| Building Size: | 50m(w) x 70m(l) x 19.5m(h) |
| Building Features: | 4-storey GMP/biotech labs with lower clearances, dense MEP (4 storeys). |
| Unit Features: | 250 sqm / unit |
| Number of Buildings: | 10 |
| Units per Building: | 56 biotech GMP lab suites |
| Total Number of Units: | 560 total units |
| Selling Price per Unit: | PHP 15,840,000.00 / unit |
| Lease Rate per Unit per Month: | PHP 132,000.00 / mo |





























